Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Incyte Biosciences Finland Oy
OY
Active
Y-tunnus 2614186-4
Pl 18, 00270
Helsinki
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2014
— employees
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Incyte Biosciences Finland Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
0M
2023
1M
2024
0M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
324
681
0
552
412
Staff expenses
−223
−341
−0
−277
−213
EBITDA
13
23
0
22
15
Depreciation & amort.
—
—
−0
−0
−0
EBIT
13
23
0
22
15
Net financials
−0
−0
0
0
11
Profit before tax
13
22
0
22
26
Tax
3
4
−0
5
5
Net profit
10
18
0
17
21
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
238
539
0
236
234
Equity
31
49
0
20
106
Long-term debt
—
—
0
0
0
Short-term debt
206
490
0
151
129
Total debt
206
490
0
151
129
Financial ratios
5-year trend
EBITDA margin
3.7%
This company
15.8%
Market median
-77% vs market
2021
2025
Equity ratio
45.0%
This company
38.2%
Market median
+18% vs market
2021
2025
Return on equity
19.8%
This company
18.4%
Market median
+8% vs market
2021
2025
Net profit margin
5.1%
This company
8.1%
Market median
-37% vs market
2021
2025
Asset turnover
1.76×
This company
1.12×
Market median
+57% vs market
2021
2025
Debt / equity
1.22×
This company
0.62×
Market median
-97% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Incyte Biosciences Finland Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
